VAERS Reports U8044AB

VAERS 2703887

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge U8044AB

gering

Staat: IL
Alter: 77,0
Geschlecht: F
Eingang: 27.10.2023
Impfdatum: 27.10.2023
Beginn: 27.10.2023
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Extra dose administered

Symptomtext

Pt said she already had the flu shot after receiving the shot.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 2686174

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge U8044AB

gering

Staat: IN
Alter: 49,0
Geschlecht: F
Eingang: 25.09.2023
Impfdatum: 19.09.2023
Beginn: 19.09.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event Product administered to patient of inappropriate age

Symptomtext

fluzone high dose quadrivalent is given to a patient under the age 65 with no reported adverse event; Initial information received on 19-Sep-2023 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a 49 years old female patient to whom fluzone high dose quadrivalent was given patient under the age 65 with no reported adverse event The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included tozinameran (comirnaty) for COVID-19 immunisation. On 19-Sep-2023, the patient received suspect influenza quadrival A-B high dose HV vaccine lot U8044AB via intramuscular route in the left deltoid for prophylactic vaccination (strength, dose and expiry date: unknown), given to a patient under the age 65 with no reported adverse event (product administered to patient of inappropriate age) (latency same day). Action taken: not applicable. At time of reporting, the outcome was Unknown for the event product administered to patient of inappropriate age. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: COMIRNATY
Allergien: -
Vorherige Impfungen: -